Before accessing the site, please choose from the following options.
Managing Director | 19 years industry experience
Managing Director 19 years industry experience
Melissa Daniels is a Managing Director of Morgan Stanley Expansion Capital. Previously, Melissa served as Co-Head and Managing Member of Morgan Stanley Venture Partners. Melissa has been an active growth equity investor and board member in numerous software, healthcare service, healthcare IT and medical device companies. Melissa's current and recent board positions include Vbrick Systems, Arcadian Management Services, Clinipace Worldwide, Discoverx, EKOS, IDeaS, National Healing, PeopleClick, and SouthernCare. Prior to joining Morgan Stanley, Melissa held operational and management roles in private companies, and also served as staff on a subcommittee of the US House of Representatives. Melissa earned a BA in Economics from the University of North Carolina at Chapel Hill and earned her MBA from the University of California at Berkeley.
Makes privately negotiated later-stage investments in technology, health care, consumer, and other sectors.
May not represent all Team Members.
The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.
All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.
Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.